AJMC November 21, 2024
Key Takeaways
- Immunotherapy in NSCLC faces challenges like high costs, limited access, and the need for optimized dosing and understanding of drug mechanisms.
- Precision medicine in breast cancer is evolving with new HER2 concepts and targeted treatments, emphasizing the need for better biomarkers.
- Sarcoma care benefits from advancements in predictive biomarkers, though challenges remain due to the rarity and heterogeneity of the disease.
- Pharmacy decision-making in oncology is crucial for optimizing treatment outcomes and managing healthcare costs, with pharmacists playing a key role.
- Equitable access to advanced cancer treatments and improved healthcare efficiency are essential for achieving value-based oncology care.
Coverage from the IVBM Regional event in Boston, Massachusetts.
The first regional event of Institute for Value-Based Medicine,®...
Today's Sponsors
Today's Sponsor